Substance / Medication

Buspirone hydrochloride

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

48 trials linked to this intervention

48
Total Trials
5
Recruiting
17
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Studying the Experiences of Children With Moderate to Profound Intellectual Disabilities in Research: A Systematic Review.
Peltomäki Satu, Granö Sirpa, Rönkkö Ella et al. · J Intellect Disabil Res · 2026
PMID: 40650453Meta-AnalysisFull text (PMC)
Healthcare Utilisation and Barriers and Facilitators of Healthcare Access for Young People With Intellectual Disability: A Systematic Review.
Kreps Felicia, Wijekulasuriya Shalini, Zurynski Yvonne et al. · J Intellect Disabil Res · 2026
PMID: 40851499Meta-AnalysisFull text (PMC)
A Systematic review of the presence and participation of students with intellectual disabilities in Spanish universities.
Serrano Fernández Laura, Viguera Monje Manuel · J Intellect Disabil · 2025
PMID: 38574375Meta-Analysis
A systematic review and pooled analysis of penetrance estimates of copy-number variants associated with neurodevelopment.
Goh Shuxiang, Thiyagarajan Lavvina, Dudding-Byth Tracy et al. · Genet Med · 2025
PMID: 39092588Meta-Analysis
Enhanced bioavailability of buspirone hydrochloride via cup and core buccal tablets: formulation and in vitro/in vivo evaluation.
Kassem Mohamed A A, Elmeshad Aliaa N, Fares Ahmed R · Int J Pharm · 2014
PMID: 24412520RCT
Development and validation of an in vitro-in vivo correlation for buspirone hydrochloride extended release tablets.
Takka Sevgi, Sakr Adel, Goldberg Arthur · J Control Release · 2003
PMID: 12586512Trial

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Buspirone hydrochloride (substance)
SNOMED CT
419484002
UMLS CUI
C0700444

Clinical Data

This intervention maps to 11 entities in the Ltrl knowledge graph.

3
Conditions
4
Biomarkers
2
Specialists
0
Symptoms
48
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.